DST awards Rs 60 crore to Mumbai Biocluster for innovation in biopharmaceuticals
Divyansh | March 5, 2024 | 03:21 PM IST | 1 min read
ICT Mumbai, IIT Bombay, TIFR, ACTREC and Khalsa College have formed Mumbai Biocluster to boost India's biopharmaceutical ecosystem.
NEW DELHI: The department of science and technology's (DST) SATHI initiative has granted Rs 60 crore to the Mumbai Biocluster, which comprises institutions such as Institute of Chemical Technology (ICT) Mumbai, IIT Bombay, Tata Institute of Fundamental Research (TIFR), Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) and Khalsa College.
Led by ICT Mumbai's vice-chancellor AB Pandit and DST-SATHI principal investigator Ratnesh Jain, the Mumbai Biocluster aims at catalysing innovation in biopharmaceuticals. Supported by Prasanna Venkatraman from ACTREC, Pratiksha Palahe from Khalsa College, Sudipta Maiti from TIFR, and Rohit Srivastava from IIT Bombay, the collaborative effort will accelerate the development of critical therapies for diseases like cancer, rare diseases, and infectious diseases.
Mumbai biocluster’s objective
The biocluster will serve as an accelerator for startups, academia, MSMEs, and industries, providing state-of-the-art infrastructure and expertise for faster development of biopharmaceutical products. With a focus on monoclonal antibodies, vaccines, mRNA technology, and cell and gene therapy, the facility will address key challenges faced during technology scale-up and validation in the drug development phase.
Also read BITS Pilani gets Rs 60 crore from DST to set up advanced research facility under SATHI scheme
Central to the biocluster's mission is the provision of a good manufacturing practice (GMP) facility, enabling drug development at an affordable cost. By bridging the gap between research and commercialization, the Mumbai Biocluster aims to propel India to the forefront of biopharmaceutical innovation, driving economic growth and improving healthcare outcomes. With the support of the DST-SATHI grant and the collective expertise of its member institutions, the Mumbai Biocluster is poised to revolutionise the landscape of biopharmaceutical research and development in India, the ICT said.
Follow us for the latest education news on colleges and universities, admission, courses, exams, research, education policies, study abroad and more..
To get in touch, write to us at news@careers360.com.
Next Story
]Featured News
]- NSO Survey: Nearly 50% of children travelling at least 1 km to school walk, more so in rural areas
- At 7 IITs, 1,495 reserved SC, ST, OBC faculty posts vacant; IIT Kharagpur alone has 710, reveals RTI data
- In a first for NEET UG Counselling, costliest medical colleges slash MBBS fees up to 40% as seats go vacant
- ISRO communication and media scholar India’s sole representative from field in world top 2% scientists list
- Boomerang effect? Jadavpur bookstalls report fourfold rise in sales after Durga Puja attack sparks resistance
- Maharashtra NEET UG Counselling: HC refuses to let medical college hold own MBBS rounds, says plea ‘premature’
- NEET PG Counselling: At private medical colleges, deemed-university tag brings up to 1,471% fee hike
- ‘Didn't call police,’ IIT Bombay deputy director tells faculty members; prof questions response
- AI engineer builds app for blind students in higher education; over 1,000 use it to read in 30 languages
- ‘Teachers know…’: In Chennai govt schools, drugs move through classrooms, playgrounds – unchecked, unreported